Cencora Inc. has published its 2025 Annual Report, highlighting a year of strong financial performance and continued growth in its role as a leading global pharmaceutical solutions organization. The report notes significant business developments, including the acquisition of Retina Consultants of America, which further strengthens Cencora’s position in the healthcare sector. The company continues to focus on improving access to therapies and supporting healthcare providers with secure and reliable delivery of pharmaceuticals and related solutions. The full report can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief on February 06, 2026, and is solely responsible for the information contained therein.